Markel Group stock has delivered a 47.2% gain over the past five years, yet current valuation checks suggest the shares now sit close to intrinsic value rather than offering a clear bargain or flashing a clear warning.

• Over five years Markel Group has returned 47.2%, which points to solid long term value creation for shareholders.
• Recent earnings strength and ongoing share repurchases can support the intrinsic value, while any setback in underwriting profitability or investment income remains a key risk for the valuation case.
• With a mixed valuation score of 4 out of 6 checks, Markel Group looks roughly in line with an intrinsic value estimate that places the stock in the about right range rather than clearly cheap or clearly expensive.

The issue now is whether Markel Group's recent fundamentals and capital returns are enough to justify holding a stock that screens as fairly valued on intrinsic and market based measures.

Is Markel Group Fairly Priced on Excess Returns?

The Excess Returns model values Markel Group by comparing what it earns on equity to the return investors require. On this view, Markel Group starts with a Book Value of $1,531.53 per share and a Stable EPS of $140.26 per share, based on forward Return on Equity estimates from analysts. The model assumes a Cost of Equity of $133.47 per share, which leaves an Excess Return of $6.79 per share and an Average Return on Equity of 7.60%. That excess is capitalised on a Stable Book Value base of $1,844.56 per share to arrive at an intrinsic value estimate of $2,036.52 per share.

Compared with the current share price, this implies Markel Group trades at roughly a 7.9% discount. On this basis, the stock screens as only mildly undervalued on intrinsic grounds rather than offering a deep discount. The strong Q2 2026 result, with higher underwriting profitability and investment income, helps explain why the current market price already sits close to the Excess Returns estimate instead of at a more obvious bargain level.

Overall, the Excess Returns workup suggests Markel Group stock appears roughly fairly valued, with only a modest tilt toward undervalued territory.

Markel Group is fairly valued according to our Excess Returns, but this can change at a moment's notice. Track the value in your watchlist or portfolio and be alerted on when to act.

Does Markel Group Look Fairly Valued on Earnings?

The P/E ratio is a useful yardstick for Markel Group because earnings are a key driver of value for an insurance and investment business. Markel Group currently trades on a P/E of 10.2x, compared with the Insurance industry average of 11.7x and a peer average of 12.0x. That puts the stock at a discount to many listed insurers on simple earnings terms.

A more tailored fair P/E ratio for Markel Group, which factors in its size, margins, risk profile and sector, comes out at 11.1x. Compared with this, the current 10.2x multiple sits only slightly below where the model would expect. This points to limited upside or downside implied by this one metric. The recent Q2 2026 earnings strength helps explain why the P/E has moved closer to that fair range, rather than looking clearly cheap.

On balance, Markel Group appears roughly fairly valued on its current P/E multiple relative to both the industry and the modelled fair ratio.

The Markel Group Narrative: What Would Justify Today's Price?

Simply Wall St Narratives pick up where this Markel Group valuation puzzle leaves off by spelling out what growth, margins and earnings paths would need to hold for the stock to be worth materially more or less than today’s price. Each Narrative sits on Markel Group's Community page and presents fair value as a specific thesis about the business that can be tracked over time instead of a one off snapshot.

Be one of the first voices in the Simply Wall St community to set out a number driven case on Markel Group, including a view on whether the recent increase in adjusted operating income and underwriting gross premium volume really supports today’s price. Share a narrative and track how your thesis holds up as new results and cash flow updates arrive.

Do you think there's more to the story for Markel Group? Head over to our Community to see what others are saying!

The Bottom Line

For Markel Group, the Excess Returns intrinsic value estimate and the current P/E both point to a stock that looks about right rather than clearly mispriced. The intrinsic value workup suggests a modest discount, while the tailored earnings multiple implies limited upside or downside on today’s figures. With a mixed valuation score, the key question from here is whether underwriting profitability and investment income can hold at levels that justify more than a small valuation gap, or whether the current price already reflects a fair read of those risks and rewards.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.